Disparities and cervical cancer

Toward the Elimination of Cancer Disparities: Clinical and Public Health Perspectives

Volumn , Issue , 2009, Pages 203-225

  Del Carmen, Marcela ^a   Diaz Montez, Teresa ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84856722841     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-89443-0_9     Document Type: Chapter

References (83)

1. Adams EK, Breen N, Joski PJ. 2007. Impact of the National Breast and Cervical Cancer Early Detection Program on mammography and pap test utilization among white, Hispanic, and African American women: 1996-2000. Cancer. (Nov 29) 109(S2):348-358.
2. American Cancer Society. Cancer Facts & Figures, 2007. Atlanta, Georgia. http://www. cancer.org/downloads/STT/CAFF2007PWSecured.pdf
3. Asian American Network for Cancer Awareness, Research and Training. http://www. aancart.org. Accessed October 18, 2007
4. Baker P, Hoel D, Mohr L, Lipsitz S, Lackland D. 2000. Racial, age, and rural/urban disparity in cervical cancer incidence. Ann Epidemiol 10(7):466-467.
5. Baquet CR, Mack KM, Mishra SI, et al. 2006. Maryland's Special Populations Network. A model for cancer disparities research, education, and training. Cancer. 107(8 Suppl):2061-2070.
6. Bazargan M, Bazargan SH, Farooq M, Baker RS. 2004. Correlates of cervical cancer screening among underserved Hispanic and African-American women. Prev Med 39(3):465-473.
7. Behbakht K, Lynch A, Teal S, Degeest K, Massad S. 2004. Social and cultural barriers to Papanicolaou test screening in an urban population. Obstet Gynecol 1046:1355-1361.
8. Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman R, Shah KV. 1995. Prevalence of human papillomarivus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) study group. J Natl Cancer Inst 87(11):796-802.
9. Burk RD, Kelly P, Feldman J, Bromberg J, Vermund SH, DeHovitz JA, Landesman SH. 1996. Declining prevalence of cervicovaginal human papillomavirus infection with age is independent of other risk factors. Sex Transm Dis 23(4):333-341.
10. Byrd TL, Peterson SK, Chavez R, Heckert A. 2004. Cervical cancer screening beliefs among young Hispanic women. Prev Med 38(2):192-197.
11. Carrillo JE, Green AR, Betancourt JR. 1999. Cross-cultural primary care: a patient-based approach. Ann Intern Med. 130(10):829-834.
12. Clifford GM, Smith JS, Plummer M, Munoz N, Franceschi S. 2003. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 88(1):63-73.
13. Committee on Infectious Diseases. Recommended Immunization Schedules for Children and Adolescents - United States 2007 Pediatrics 119.
14. Coughlin SS,King J,Richards TB, Ekwueme DU. 2006. Cervical cancer screening amongwomen in metropolitan areas of the United States by individual-level and area-based measures of socioeconomic status, 2000 to 2002. Cancer Epidemiol Biomarkers Prev 15(11):2154-2159.
15. Cuzick J, Szarewski A, Terry G, Ho L, Hanby A, Maddox P, Anderson M, Kocjan G, Steele ST, Guillebaud J. 1995. Human papillomavirus testing in primary cervical screening. Lancet 345(8964):1533-1536.
16. DATA 2010. The Healthy People 2010 database. The Centers for Disease Control and Prevention. http://wonder.cdc.gov/scripts/broker.exe. Accessed May 15, 2007.
17. del Carmen MG, Fidnley M, Muzikansky A, Roche M, Verrill CL, Horowtiz NE, Seiden M. 2007. Demographic, risk factor, and knowledge differences between Latinas and non- Latinas referred to colposcopy. Gynecol Oncol. (Jan) 104(1):70-76.
18. del Carmen MG, Montz FJ, Bristow RE, Bovicelli A, Cornelieson T, Trimble E. 1999. Ethnic differences in patterns of care of stage IA1 and stage IA2 cervical cancer: A SEER database study. Gyn Oncol 75:113-117.
19. Denny L, Quinn M, Sankaranarayanan R. 2006. Screening for cervical cancer in developing countries. Vaccine 24(3):S71-S77.
20. Department of Health and Human Services. Medicaid Special Coverage Conditions. Breast and Cervical Cancer: Prevention and Treatment. http://www.cms.hhs.gov/MedicaidSpecialCovCond/02-BreastandCervicalCancer- PreventionandTreatment.asp. Accessed November 01, 2007.
21. Dignamm JJ. Differences in breast cancer prognosis among African American and Caucasian women. 2000. CA Cancer J Clin. 50:50-64.
22. Ell K, Vourlekis B, Muderspach L, et al. 2002. Abnormal cervical screen follow-up among low-income Latinas: Project SAFe. J Womens Health Gend Based 11(7):639-651.
23. Ferrante JM, Gonzalez EC, Roetzheim RG, Pal N, Woodard L. 2000. Clinical and demographic predictors of late-stage cervical cancer. Arch Fain Med 9(5):439-445.
24. Finkelstein JB. 2007. Screening program serves fraction of those eligible. J Natl Cancer Inst. (Feb 21) 99(4):270-271.
25. Fowler T, Steakley C, Garcia AR, Kwok J, Bennett LM. 2006. Reducing disparities in the burden of cancer: the role of patient navigators. PLoS Med. (Jul) 3(7):e193.
26. Flores E, Espinoza P, Jacobellis J, Bakemeier R, Press N. 2006. The greater Denver Latino Cancer Prevention/Control Network: prevention and research through a communitybased approach. Cancer. 107(8 Suppl):2034-2042.
27. Freeman HP, Vydelingum NA. 2006. The role of the special populations networks program in eliminating cancer health disparities. Cancer. (Oct 15) 107(8 Suppl):1933-1935.
28. Gany FM, Shah SM, Changrani J. 2006. New York City's immigrant minorities. Reducing cancer health disparities. Cancer. 107(8 Suppl):2071-2081.
29. Goel MS, Wee CC, McCarthy EP, Davis RB, Ngo-Metzger Q, Phillips RS. 2003. Racial and ethnic disparities in cancer screening: the importance of foreign birth as a barrier to care. J Gen Intern Med 18(12):1028-1035.
30. Hansen LK, Feigl P, Modiano MR, et al. 2005. An educational program to increase cervical and breast cancer screening in Hispanic women: a Southwest Oncology Group study. Cancer Nurs. 28(1):47-53.
31. Harlan LC, Bernstein AB, Kessler LG. 1991. Cervical cancer screening: who is not screened and why? Am J Public Health 81(7):885-890.
32. Harris R, Leininger L. 1993. Preventive care in rural primary care practice. Cancer 72(3 Suppl):1113-1118.
33. Healthy People 2010. The Centers for Disease Control and Prevention. http://wonder.cdc. gov/DATA2010.
34. Healthy People 2010 US Department of Health and Human Services http://www.healthypeople. gov/default.htm
35. Hiatt RA, Pasick RJ, Stewart S, Bloom J, Davis P, Gardiner P, Johnston M, Luce J, Schorr K, Brunner W, Stroud F. 2001. Community-based cancer screening for underserved women: design and baseline findings from the Breast and Cervical Cancer Intervention Study. Prev Med. 33(3):190-203.
36. Hildesheim A, Gravitt P, SchiffmanMH,Kurman RJ, Barnes W, Jones S, Tchabo JG, Brinton LA,CopelandC, Epp J, et al. 1993. Determinants of genital human papillomavirus infection in low-income women inWashington, D. C. Sex Transm Dis 20(5):279-285.
37. Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD. 1998. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 338(7):423-428.
38. Howe HL,WuX,RiesLA,Cokkinides V,AhmedF, Jemal A, Miller B, WilliamsM,Ward E, Wingo PA, Ramirez A, Edwards BK. 2006. Annual report to the nation on the status of cancer, 1975-2003, featuring cancer among U.S. Hispanic/Latino populations. Cancer 107(8):1711-1742.
39. Howell EA, Chen YT, Concato J. 1999. Differences in cervical cancer mortality among black and white women. Obstet Gynecol. 94:509-15.
40. Jackson FE, Chu KC, Garcia R. 2006. Special Populations Networks - how this innovative community-based initiative affected minority and underserved research programs. Cancer. 107(8 Suppl):1939-1944.
41. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 57(1):42-66.
42. Kamangar F, Dores GM, Anderson WF. 2006. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 224(14):2137-2150.
43. Kiefe CI, Funkhouser E, Fouad MN, May DS. 1998. Chronic disease as a barrier to breast and cervical cancer screening. J Gen Intern Med 13(6):357-365.
44. Krieger N, Quesenberry C Jr, Peng T, Horn-Ross P, Stewart S, Brown S, Swallen K, Guillermo T, Suh D, Alvarez-Martinez L, Ward F. 1999. Social class, race/ethnicity, and incidence of breast, cervix, colon, lung, and prostate cancer among Asian, Black, Hispanic, and White residents of the San Francisco Bay Area, 1988-92 (United States). Cancer Causes Control 10(6):525-537.
45. Ley C, Bauer HM, Reingold A, Schiffman MH, Chambers JC, Tashiro CJ, ManosMM.1991. Determinants of genital human papillomavirus infection in young women. J Natl Cancer Inst 83(14):997-1003.
46. Lorincz AT, Reid R, Jenson AB, Greenberg MD, Lancaster W, Kurman R J. 1992. Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet Gynecol 79(30):328-337.
47. Lorincz AT, Reid R. 1989. Association of human papillomavirus with gynecologic cancer. Curr Opin Oncol 1(1):123-132.
48. Margolis KL, Lurie N, McGovern PG, Tyrrell M, Slater JS. 1998. Increasing breast and cervical cancer screening in low-income women. J Gen Intern Med. 13(8):515-521.
49. Massad LS, Verhulst SJ, Hagemeyer M, Brady P. 2006. Knowledge of the cervical cancer screening process among rural and urban Illinois women undergoing colposcopy. J Low Genit Tract Dis. 10(4):252-255.
50. McDougall JA, Madeleine MM, Dailing JR, Li CI. 2007. Racial and ethnic disparities in cervical cancer incidence rates in the United States, 1992-2003. Cancer Causes Control 18(10):1175-1186.
51. McGuire TR, Leypoldt M, Narducci WA, Ward K. 2007. Accessing rural populations: role of the community pharmacist in a breast and cervical cancer screening programme. J Eval Clin Pract. 13(1):146-149.
52. Mensah G. 2006. Racial and Ethnic Approaches to Community Health (REACH) 2010. The Centers for Disease Control and Prevention. Atlanta, GA: U.S. Department of Health and Human Services.
53. Merrill RM, Merrill AV, Mayer LS. 2000. Factors associated with no surgery or radiation therapy for invasive cervical cancer in Black and White women. Ethn Dis. 10:248-56.
54. Miller SM, Siejak KK, Schroeder CM, Lerman C, Hernandez E, Helm CW. 1997. Enhancing adherence following abnormal Pap smears among low-income minority women: a preventive telephone counseling strategy. J Natl Cancer Inst. 89(10):703-708.
55. Mock J, McPhee SJ, Nguyen T, et al. 2007. Effective Lay Health Worker Outreach and Media-Based Education for Promoting Cervical Cancer Screening Among Vietnamese American Women. Am J Public Health 97:1693-1700.
56. Mundt AJ, Connell PP, Campbell T, Hwang JH, Rotmensch J, Waggoner S. 1998. Race and clinical outcome in patients with carcinoma of the uterine cervix treated with radiation therapy. Gynecol Oncol. 71:151-8.
57. Newmann SJ, Garner EO. 2005. Social inequities along the cervical cancer continuum: a structured review. Cancer Causes Control. 16: 63-70.
58. Nuovo GJ, Pedemonte B. M. 1990. Human papillomavirus types and recurrent cervical warts. JAMA 263(9):1223-1226.
59. O'Malley AS, Forrest CB, Mandelblatt J. 2002. Adherence of low-income women to cancer screening recommendations. J Gen Intern Med. 17(2):144-154.
60. O'Malley AS, Forrest CB. 2002. Beyond the examination room: primary care performance and the patient-physician relationship for low-income women. J Gen InternMed. 17(1):66-74.
61. O'Malley CD, Shema SJ, Clarke LS, Clarke CA, Perkins CI. 2006. Medicaid status and stage at diagnosis of cervical cancer. Am J Public Health 96(12):2179-2185.
62. Patel DA, Barnholtz-Sloan JS, Patel MK, Malone JM Jr, Chuba PJ, Schwartz K. 2005. A population-based study of racial and ethnic differences in survival among women with invasive cervical cancer: analysis of Surveillance, Epidemiology, and End Results data. Gynecol Oncol 97(2):550-558.
63. Peyton CL, Gravitt PE, Hunt WC, Hundley RS, Zhao M, Apple RJ, Wheeler CM. 2001. Determinants of genital human papillomavirus detection in a U. S. population. J Infect Dis 183(11):1554-1564.
64. Population Estimates. The US Census Bureau. 2007. http://www.census.gov/ popest/estimates. php. Accessed November 1, 2007.
65. Ries L, Harkins D, Krapcho M, Mariotto A, Miller BA, Feuer EJ, Clegg L, Eisner MP, Horner MJ, Howlader N, Hayat M, Hankey BF, Edwards BK (eds). 2005. SEER Cancer Statistics Review, 1975-2004
66. National Cancer Institute. Bethesda, MD, based on November 2005 SEER data submission, posted to the SEER web site. http://seer.cancer. gov/csr/1975-2004/.
67. Ries LAG, Harkins D, Krapcho M, Mariotto A, Miller BA, Feuer EJ, Clegg L, Eisner MP, Horner MJ, Howlader N, Hayat M, Hankey BF, Edwards BK (eds). 2006. SEER Cancer Statistics Review, 1975-2003, National Cancer Institute. Bethesda, MD, http://seer.cancer. gov/csr/1975-2003/, based on November 2005 SEER data submission, posted to the SEER web site, 2008
68. Riley GF, Potosky AL, Lubitz JD, Brown ML. 1994. Stage of cancer at diagnosis for Medicare HMO and fee-for-service enrollees. Am J Public Health 84(10):1598-1604.
69. Russell AH, Shingleton HM, Jones WB, Stewart AK, Fremgen A, Winchester DP, et al. 1998. Trends in the use of radiation and chemotherapy in the initial management of patients with carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys. 40:605-13.
70. Sankaranarayanan R, Ferlay J. 2006. Worldwide burden of gynaecological cancer: the size of the problem. Best Pract Res Clin Obstet Gynaecol 20(2):207-225.
71. Ryerson AB, Benard, V. B., and Major, A.C. 2005. The National Breast and Cervical Cancer Early Detection Program: 1991-2002 National Report. Atlanta, GA: The Centers for Disease Control and Prevention
72. Saraiya M, Ahmed F, Krishnan S, Richards TB, Unger ER, Lawson HW. 2007. Cervical cancer incidence in a prevaccine era in the United States, 1998-2002. Obstet Gynecol 109(2 Pt 1):360-370.
73. Shah M, Zhu K, Wu H, Potter J. 2006. Hispanic acculturation and utilization of cervical cancer screening in the US. Prev Med 42(2):146-149.
74. Shavers VL, Brown ML. 2002. Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst. Mar 94(5):334-357.
75. Stone KM. 1995. Human papillomavirus infection and genital warts: update on epidemiology and treatment. Clin Infect Dis 20(Suppl 1):S91-S97.
76. Taylor VM, Hislop TG, Jackson JC, et al. 2002. A randomized controlled trial of interventions to promote cervical cancer screening among Chinese women in North America. J Natl Cancer Inst. 94(9):670-677.
77. Tejeda S, Thompson B, Coronado GD, Rees JM. 2006. A cervical cancer curriculum for Hispanic adolescents in rural high schools: a pilot study. J Health Care Poor Underserved. 17(4):734-744.
78. The Centers for Disease Control and Prevention. National Breast and Cervical Cancer Early Detection Program. http://www.cdc.gov/cancer/nbccedp/. Accessed March 29, 2007.
79. Thoms WW, Unger ER, Carisio R, Nisenbaum R, Spann CO, Horowitz IR, et al. 1998. Clinical determinants of survival from stage Ib cervical cancer in an inner-city hospital. J Natl Med Assoc. 90:303-8.
80. Tiro JA, Meissner HI, Kobrin S, Chollette V. 2007. What do women in the U.S. know about human papillomavirus and cervical cancer? Cancer Epidemiol Biomarkers Prev 16(2):288-94.
81. U.S. Census Bureau, 2004, ''U.S. Interim Projections by Age, Sex, Race, and Hispanic Origin''. http://www.census.gov/ipc/www/usinterimproj/
82. Wasserman M, Bender D, Lee S-Y D. 2007. Use of Preventive Maternal and Child Health Services by Latina Women. Med Care Res Rev. 64(1):4-45.
83. Winstead E. 2005. tHelping Patients Navigate the Health Care System. NCI Cancer Bulletin. NCI Cancer Bulleting. Vol 2